Skip to menu Skip to content Skip to footer

2015

Journal Article

Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancer

Roberts, Matthew J., Chow, Clement W., Schirra, Horst J., Richards, Renee, Buck, Marion, Selth, Luke A., Doi, Suhail A. R., Samaratunga, Hema, Perry-Keene, Joanna, Payton, Diane, Yaxley, John, Lavin, Martin F. and Gardiner, Robert A. (2015). Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancer. Prostate, 75 (5), 539-549. doi: 10.1002/pros.22942

Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancer

2015

Journal Article

Mesenchymal tumors of adult kidney

Samaratunga, Hemanali and Delahunt, Brett (2015). Mesenchymal tumors of adult kidney. Seminars in Diagnostic Pathology, 32 (2), 160-171. doi: 10.1053/j.semdp.2015.02.007

Mesenchymal tumors of adult kidney

2015

Journal Article

Pleomorphic giant cell carcinoma of the urinary bladder: an extreme form of tumour de-differentiation

Samaratunga, Hemamali, Delahunt, Brett, Egevad, Lars, Adamson, Michael, Hussey, David, Malone, Greg, Hoyle, Kirsten, Nathan, Tim, Kerle, David, Ferguson, Peter and Nacey, John N. (2015). Pleomorphic giant cell carcinoma of the urinary bladder: an extreme form of tumour de-differentiation. Histopathology, 68 (4), 533-540. doi: 10.1111/his.12785

Pleomorphic giant cell carcinoma of the urinary bladder: an extreme form of tumour de-differentiation

2015

Conference Publication

Utility of cytokeratin 7, leptin and caveolin-1 biomarkers in differentiation of chromophobe renal cell carcinoma and renal oncocytoma

Ng, K. L., Small, D., Morais, C., Samaratunga, H., Gobe, G. and Wood, S. (2015). Utility of cytokeratin 7, leptin and caveolin-1 biomarkers in differentiation of chromophobe renal cell carcinoma and renal oncocytoma. 24th Malaysian Urological Conference (MUC), Malaysia, Nov 19, 2015. West Sussex, United Kingdom: Wiley-Blackwell.

Utility of cytokeratin 7, leptin and caveolin-1 biomarkers in differentiation of chromophobe renal cell carcinoma and renal oncocytoma

2015

Conference Publication

Expression of immunohistochemical Caveolin-1 staining can aid in differentiation between Chromophobe renal cell carcinoma and Renal Oncocytoma

Ng, K., Small, D., Morais, C., Samaratunga, H., Gobe, G. and Wood, S. (2015). Expression of immunohistochemical Caveolin-1 staining can aid in differentiation between Chromophobe renal cell carcinoma and Renal Oncocytoma. 68th Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Adelaide, SA Australia, 11-14 April 2015. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/bju.13072

Expression of immunohistochemical Caveolin-1 staining can aid in differentiation between Chromophobe renal cell carcinoma and Renal Oncocytoma

2015

Conference Publication

Diagnostic performance of PCA3, Hepsin and microRNA biomarkers in ejaculate in combination with serum PSA for the detection and triaging of prostate cancer

Roberts, Chow, Schirra, Richards, Buck, Seth, Doi, Samaratunga, Perry-Keene, Payton, Yaxley, Lavin and Gardiner (2015). Diagnostic performance of PCA3, Hepsin and microRNA biomarkers in ejaculate in combination with serum PSA for the detection and triaging of prostate cancer. 68th Annual Scientific Meeting of the Urological-Society-of-Australia-and-New Zealand, Adelaide, AUSTRALIA, APR 11-14, 2015. HOBOKEN: WILEY-BLACKWELL.

Diagnostic performance of PCA3, Hepsin and microRNA biomarkers in ejaculate in combination with serum PSA for the detection and triaging of prostate cancer

2015

Conference Publication

True false negative of MRI scans for prostate cancer screening. How often does MRI miss?

Scott, S., Samaratunga, H., Yaxley, J., Gianduzzo, T., Kua, B., Coughlin, G. and Breckenridge, M. (2015). True false negative of MRI scans for prostate cancer screening. How often does MRI miss?. 68th Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Adelaide, SA Australia, 11-14 April 2015. Chichester, West Sussex United Kingdom: Wiley-Blackwell. doi: 10.1111/bju.13072

True false negative of MRI scans for prostate cancer screening. How often does MRI miss?

2015

Conference Publication

Systematic review and meta-analysis of immunohistochemical biomarkers in differentiation and diagnosis of chromophobe renal cell carcinoma and renal oncocytoma

Ng, K., Bernard, A., Morais, C., Samaratunga, H., Gobe, G. and Wood, S. (2015). Systematic review and meta-analysis of immunohistochemical biomarkers in differentiation and diagnosis of chromophobe renal cell carcinoma and renal oncocytoma. 68th Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Adelaide, SA Australia, 11-14 April 2015. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/bju.13073

Systematic review and meta-analysis of immunohistochemical biomarkers in differentiation and diagnosis of chromophobe renal cell carcinoma and renal oncocytoma

2015

Journal Article

Active surveillance for prostate cancer: the role of the pathologist

Delahunt, Brett, Hammond, Elizabeth, Egevad, Lars, Samaratunga, Hemamali, Srigley, John R., Humphrey, Peter A., Rubin, Mark, Epstein, Jonathan I., Lin, Daniel W., Gore, John L., Nacey, John N., Klotz, Laurence, Sandler, Howard, Zietman, Anthony L., Holden, Stuart, Montironi, Rodolfo, Evans, Andrew J., McKenney, Jesse K., Berney, Dan, Wheeler, Thomas M., Chinnaiyan, Arul M., True, Lawrence, Knudsen, Beatrice and Amin, Mahul B. (2015). Active surveillance for prostate cancer: the role of the pathologist. Pathology, 47 (1), 1-3. doi: 10.1097/PAT.0000000000000186

Active surveillance for prostate cancer: the role of the pathologist

2015

Conference Publication

Significance of NF kappa B isoform p65 as a biomarker for renal cancers in a cohort of Malaysian patients

Ng, K., Small, D., Morais, C., Samaratunga, H., Yap, N. Y., Rajandram, R., Pailoor, J., Razack, A. H., Gobe, G. and Wood, S. (2015). Significance of NF kappa B isoform p65 as a biomarker for renal cancers in a cohort of Malaysian patients. 68th Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Adelaide, SA Australia, 11-14 April 2015. Chichester, West Sussex, United Kingdom Publisher Wiley-Blackwell Publishing: Chichester, West Sussex, United Kingdom Publisher Wiley-Blackwell Publishing. doi: 10.1111/bju.13073

Significance of NF kappa B isoform p65 as a biomarker for renal cancers in a cohort of Malaysian patients

2014

Journal Article

Les tumeurs rénales : recommandations de la conférence de consensus de l’International Society of Urologic Pathology (ISUP) 2012 = Renal tumors: The International Society of Urologic Pathology (ISUP) 2012 consensus conference recommendations

Rioux-Leclercq, Nathalie, Ferran, Algaba, Mahul, Amin, Argani, Pedram, Billis, Athanase, Bonsib, Stephen, Cheng, Liang, Cheville, John, Eble, John, Egevad, Lars, Epstein, Jonathan, Grignon, David, Hes, Ondrej, Humphrey, Peter, Magi-Galluzzi, Cristina, Martignoni, Guido, McKenney, Jesse, Merino, Maria, Moch, Holger, Montironi, Rodolfo, Netto, George, Reuter, Viktor, Samaratunga, Hemamali, Shen, Steven, Srigley, John, Tamboli, Pheroze, Tan, Puay Hoon, Tickoo, Satish, Trpkov, Kiril ... Comperat, Eva (2014). Les tumeurs rénales : recommandations de la conférence de consensus de l’International Society of Urologic Pathology (ISUP) 2012 = Renal tumors: The International Society of Urologic Pathology (ISUP) 2012 consensus conference recommendations. Annales de Pathologie, 34 (6), 448-461. doi: 10.1016/j.annpat.2014.10.003

Les tumeurs rénales : recommandations de la conférence de consensus de l’International Society of Urologic Pathology (ISUP) 2012 = Renal tumors: The International Society of Urologic Pathology (ISUP) 2012 consensus conference recommendations

2014

Journal Article

Optimising pre-analytical factors affecting quality of prostate biopsies: the case for site specific labelling and single core submission

Srigley, John R., Delahunt, Brett, Egevad, Lars, Samaratunga, Hemamali and Evans, Andrew J. (2014). Optimising pre-analytical factors affecting quality of prostate biopsies: the case for site specific labelling and single core submission. Pathology, 46 (7), 579-580. doi: 10.1097/PAT.0000000000000183

Optimising pre-analytical factors affecting quality of prostate biopsies: the case for site specific labelling and single core submission

2014

Journal Article

Value of uroplakin III in distinguishing variants of primary bladder urothelial carcinoma from malignancy metastatic to the urinary bladder

Klopfer, Kiara, Delahunt, Brett, Adamson, Michael and Samaratunga, Hemamali (2014). Value of uroplakin III in distinguishing variants of primary bladder urothelial carcinoma from malignancy metastatic to the urinary bladder. Anticancer Research, 34 (11), 6779-6784.

Value of uroplakin III in distinguishing variants of primary bladder urothelial carcinoma from malignancy metastatic to the urinary bladder

2014

Journal Article

Effective maybe, but is it cost-effective? A reply

Perry-Keene, Joanna, Ferguson, Peter, Samaratunga, Hemamali, Nacey, John N. and Delahunt, Brett (2014). Effective maybe, but is it cost-effective? A reply. Histopathology, 65 (5), 729-730. doi: 10.1111/his.12438

Effective maybe, but is it cost-effective? A reply

2014

Journal Article

Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist

Montironi, Rodolfo, Hammond, Elizabeth H., Lin, Daniel W., Gore, John L., Srigley, John R., Samaratunga, Hema, Egevad, Lars, Rubin, Mark A., Nacey, John, Klotz, Laurence, Sandler, Howard, Zietman, Anthony L., Holden, Stuart, Humphrey, Peter A., Evans, Andrew J., Delahunt, Brett, McKenney, Jesse K., Berney, Daniel, Wheeler, Thomas M., Chinnaiyan, Arul, True, Lawrence, Knudsen, Beatrice, Epstein, Jonathan I. and Amin, Mahul B. (2014). Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist. Virchows Archiv, 465 (6), 623-628. doi: 10.1007/s00428-014-1668-5

Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist

2014

Journal Article

The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Soci

Amin, Mahul B., Lin, Daniel W., Gore, John L., Srigley, John R., Samaratunga, Hema, Egevad, Lars, Rubin, Mark, Nacey, John, Carter, H. Ballentine, Klotz, Laurence, Sandler, Howard, Zietman, Anthony L., Holden, Stuart, Montironi, Rodolfo, Humphrey, Peter A., Evans, Andrew J., Epstein, Jonathan I., Delahunt, Brett, McKenney, Jesse K., Berney, Dan, Wheeler, Thomas M., Chinnaiyan, Arul M., True, Lawrence, Knudsen, Beatrice and Hammond, M. Elizabeth H. (2014). The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Soci. Archives of Pathology and Laboratory Medicine, 138 (10), 1387-1405. doi: 10.5858/arpa.2014-0219-SA

The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Soci

2014

Journal Article

Percutaneous renal tumour biopsy

Delahunt, Brett, Samaratunga, Hemamali, Martignoni, Guido, Srigley, John R., Evans, Andrew J. and Brunelli, Matteo (2014). Percutaneous renal tumour biopsy. Histopathology, 65 (3), 295-308. doi: 10.1111/his.12495

Percutaneous renal tumour biopsy

2014

Journal Article

Diagnostic criteria for ductal adenocarcinoma of the prostate: interobserver variability among 20 expert uropathologists

Seipel, Amanda H., Delahunt, Brett, Samaratunga, Hemamali, Amin, Mahul, Barton, Joel, Berney, Daniel M., Billis, Athanase, Cheng, Liang, Comperat, Eva, Evans, Andrew, Fine, Samson W., Grignon, David, Humphrey, Peter A., Magi-Galluzzi, Cristina, Montironi, Rodolfo, Sesterhenn, Isabell, Srigley, John R., Trpkov, Kiril, van der Kwast, Theo, Varma, Murali, Zhou, Ming, Ahmad, Amar, Moss, Sue and Egevad, Lars (2014). Diagnostic criteria for ductal adenocarcinoma of the prostate: interobserver variability among 20 expert uropathologists. Histopathology, 65 (2), 216-227. doi: 10.1111/his.12382

Diagnostic criteria for ductal adenocarcinoma of the prostate: interobserver variability among 20 expert uropathologists

2014

Journal Article

Immunohistochemical profile of ductal adenocarcinoma of the prostate

Seipel, Amanda H., Samaratunga, Hemamali, Delahunt, Brett, Wiklund, Fredrik, Wiklund, Peter, Lindberg, Johan, Grönberg, Henrik and Egevad, Lars (2014). Immunohistochemical profile of ductal adenocarcinoma of the prostate. Virchows Archiv, 465 (5), 559-565. doi: 10.1007/s00428-014-1636-0

Immunohistochemical profile of ductal adenocarcinoma of the prostate

2014

Journal Article

A progress report on a prospective randomised trial of open and robotic prostatectomy

Gardiner, Robert A., Coughlin, Geoffrey D., Yaxley, John W., Dunglison, Nigel T., Occhipinti, Stefano, Younie, Sandra J., Carter, Rob C., Williams, Scott G., Medcraft, Robyn J., Samaratunga, Hema M., Perry-Keene, Joanna L., Payton, Diane J., Lavin, Martin F. and Chambers, Suzanne K. (2014). A progress report on a prospective randomised trial of open and robotic prostatectomy. European Urology, 65 (3), 512-515. doi: 10.1016/j.eururo.2013.10.031

A progress report on a prospective randomised trial of open and robotic prostatectomy